NVO's new U.S. pricing deal for Ozempic and Wegovy expands access but adds uncertainty to its growth and profit outlook.

Filmmaker Hansal Mehta advocates for open discussions about modern medications like Ozempic and Mounjaro, emphasizing their ...

Insurance data reveals dramatic regional differences in Ozempic and Mounjaro usage, with obesity-heavy states prescribing GLP ...

As can dietary fibers. A systematic review and meta-analysis published in September 2025 found that dietary fiber supplements ...

Gordon Ramsay slams restaurants creating special Ozempic menus for weight loss drug users, calling the trend 'absolute bulls- ...

Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss, though industry-funded ...

Drugs like Ozempic, known collectively as GLP-1 receptor agonists, have become more widely used in recent years. Though they ...

Savannah Chrisley shared that she plans to begin using a GLP-1 medication to help her lose 25 pounds after previously trying ...

This article was reviewed by Lynn Marie Morski, MD, JD. Does Ozempic® Cause Bone Loss? Key takeaways: Taking Ozempic® may ...

Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro, which is also used to treat diabetes in a ...

People taking GLP-1 meds could see costs drop in 2026, thanks to a new federal deal with Eli Lilly and Novo Nordisk, the ...

Recent Gallup data shows a decline in U.S. obesity rates, likely linked to widespread use of GLP-1 drugs like Ozempic and Wegovy.